Cryo-Cell International(CCEL) - 2023 Q1 - Quarterly Report

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended February 28, 2023 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from to Commission File Number 001-40767 DELAWARE 22-3023093 (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 700 Brooke ...